Immucor India Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 4.18 Cr
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 37.88%
- Profit Growth -22.77%
- Ebitda -57.90%
- Net Worth 4.26%
- Total Assets 22.25%
About Immucor India
Immucor India Private Limited (IIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 10 March 2012 and has a history of 12 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.18 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ramona Chopra and Vishal Gupta serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85190DL2012FTC232632
- Company No.
232632
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
10 Mar 2012
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Immucor India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramona Chopra  | Managing Director | 10-Mar-2012 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishal Gupta | Whole-Time Director | 09-Jan-2015 | Current |
Financial Performance of Immucor India.
Immucor India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 37.88% increase. The company also saw a substantial fall in profitability, with a 22.77% decrease in profit. The company's net worth moved up by a moderate rise of 4.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Immucor India?
In 2023, Immucor India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Immucor India?
Unlock and access historical data on people associated with Immucor India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Immucor India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Immucor India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
